Proteomics reveals drastic increase of extracellular matrix proteins collagen and dermatopontin in the aged mdx diaphragm model of Duchenne muscular dystrophy

International Journal of Molecular Medicine

Volumn 30, Issue 2, 2012, Pages 229-234

  Carberry, Steven ^a   Zweyer, Margit ^b   Swandulla, Dieter ^b   Ohlendieck, Kay ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Collagen; Dermatopontin; Diaphragm; Muscular dystrophy; Proteomics

Indexed keywords

ALPHA CRYSTALLIN; COLLAGEN; DERMATOPONTIN; DYSTROPHIN; SCLEROPROTEIN; UNCLASSIFIED DRUG; VIMENTIN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MODEL; DIAPHRAGM MUSCLE; DUCHENNE MUSCULAR DYSTROPHY; DYSTROPHINOPATHY; IMMUNOBLOTTING; MASS SPECTROMETRY; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS;

AGE FACTORS; ANIMALS; CHONDROITIN SULFATE PROTEOGLYCANS; COLLAGEN; DIAPHRAGM; EXTRACELLULAR MATRIX PROTEINS; MASS SPECTROMETRY; MICE; MICE, INBRED MDX; MUSCULAR DYSTROPHY, DUCHENNE; PROTEOME; PROTEOMICS;

EID: 84863556161     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1006     Document Type: Article

References (50)

1. Le Rumeur E, Winder SJ and Hubert JF: Dystrophin: more than just the sum of its parts. Biochim Biophys Acta 1804: 1713-1722, 2010.
2. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, et al: Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9: 77-93, 2010.
3. Durbeej M and Campbell KP: Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev 12: 349-361, 2002.
4. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG and Barnard PJ: The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244: 1578-1580, 1989.
5. Ohlendieck K and Campbell KP: Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol 115: 1685-1694, 1991.
6. Bulfield G, Siller WG, Wight PA and Moore KJ: X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 81: 1189-1192, 1984.
7. Marques MJ, Ferretti R, Vomero VU, Minatel E and Neto HS: Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy. Muscle Nerve 35: 349-353, 2007.
8. Torres LF and Duchen LW: The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates. Brain 110: 269-299, 1987.
9. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT and Kell AM: The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352: 536-539, 1991.
10. Menke A and Jockusch H: Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse. Nature 349: 69-71, 1991.
11. Lynch GS, Rafael JA, Chamberlain JS and Faulkner JA: Contraction-induced injury to single permeabilized muscle fibers from mdx, transgenic mdx, and control mice. Am J Physiol Cell Physiol 279: C1290-C1294, 2000.
12. Allen DG, Gervasio OL, Yeung EW and Whitehead NP: Calcium and the damage pathways in muscular dystrophy. Can J Physiol Pharmacol 88: 83-91, 2010.
13. + channels. Proc Natl Acad Sci USA 97: 4950-4955, 2000.
14. Partridge TA, Morgan JE, Coulton GR, Hoffman EP and Kunkel LM: Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337: 176-179, 1989.
15. Wells DJ and Wells KE: Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD? Neuromuscul Disord 12: S11-S22, 2002.
16. Doran P, Wilton SD, Fletcher S and Ohlendieck K: Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm. Proteomics 9: 671-685, 2009.
17. Spurney CF, Gordish-Dressman H, Guerron AD, Sali A, Pandey GS, Rawat R, Van Der Meulen JH, Cha HJ, Pistilli EE, Partridge TA, et al: Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures. Muscle Nerve 39: 591-602, 2009.
18. Partridge TA: Impending therapies for Duchenne muscular dystrophy. Curr Opin Neurol 24: 415-422, 2011.
19. Lefaucheur JP, Pastoret C and Sebille A: Phenotype of dystrophinopathy in old mdx mice. Anat Rec 242: 70-76, 1995.
20. Lynch GS, Hinkle RT, Chamberlain JS, Brooks SV and Faulkner JA: Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old. J Physiol 535: 591-600, 2001.
21. Pastoret C and Sebille A: Age-related differences in regeneration of dystrophic (mdx) and normal muscle in the mouse. Muscle Nerve 18: 1147-1154, 1995.
22. Pastoret C and Sebille A: MDX mice show progressive weakness and muscle deterioration with age. J Neurol Sci 129: 97-105, 1995.
23. Wineinger MA, Abresch RT, Walsh SA and Carter GT: Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice. Am J Phys Med Rehabil 77: 20-27, 1998.
24. 2+ homeostasis during fatigue. Exp Physiol 95: 641-656, 2010.
25. Chamberlain JS, Metzger J, Reyes M, Townsend D and Faulkner JA: Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J 21: 2195-2204, 2007.
26. Irintchev A, Zweyer M and Wernig A: Impaired functional and structural recovery after muscle injury in dystrophic mdx mice. Neuromuscul Disord 7: 117-125, 1997.
27. Mouisel E, Vignaud A, Hourde C, Butler-Browne G and Ferry A: Muscle weakness and atrophy are associated with decreased regenerative capacity and changes in mTOR signaling in skeletal muscles of venerable (18-24-month-old) dystrophic mdx mice. Muscle Nerve 41: 809-818, 2010.
28. Doran P, Martin G, Dowling P, Jockusch H and Ohlendieck K: Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP. Proteomics 6: 4610-4621, 2006.
29. Lewis C, Jockusch H and Ohlendieck K: Proteomic profiling of the dystrophin-deficient MDX heart reveals drastically altered levels of key metabolic and contractile proteins. J Biomed Biotechnol 2010: 648501, 2010.
30. Lewis C and Ohlendieck K: Proteomic profiling of naturally protected extraocular muscles from the dystrophin-deficient mdx mouse. Biochem Biophys Res Commun 396: 1024-1029, 2010.
31. Rabilloud T, Strub JM, Luche S, van Dorsselaer A and Lunardi J: A comparison between Sypro Ruby and ruthenium II tris (batho-phenanthroline disulfonate) as fluorescent stains for protein detection in gels. Proteomics 1: 699-704, 2001.
32. Gannon J, Staunton L, O'Connell K, Doran P and Ohlendieck K: Phosphoproteomic analysis of aged skeletal muscle. Int J Mol Med 22: 33-42, 2008.
33. Vainzof M, Ayub-Guerrieri D, Onofre PC, Martins PC, Lopes VF, Zilberztajn D, Maia LS, Sell K and Yamamoto LU: Animal models for genetic neuromuscular diseases. J Mol Neurosci 34: 241-248, 2008.
34. Guenet JL: Animal models of human genetic diseases: do they need to be faithful to be useful? Mol Genet Genomics 286: 1-20, 2011.
35. Banks GB and Chamberlain JS: The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies. Curr Top Dev Biol 84: 431-453, 2008.
36. Lewis C, Carberry S and Ohlendieck K: Proteomic profiling of X-linked muscular dystrophy. J Muscle Res Cell Motil 30: 267-269, 2009.
37. Ge Y, Molloy MP, Chamberlain JS and Andrews PC: Proteomic analysis of mdx skeletal muscle: Great reduction of adenylate kinase 1 expression and enzymatic activity. Proteomics 3: 1895-1903, 2003.
38. 2+-binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle. Eur J Biochem 271: 3943-3952, 2004.
39. Gardan-Salmon D, Dixon JM, Lonergan SM and Selsby JT: Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice. Eur J Appl Physiol 111: 2763-2773, 2011.
40. Doran P, Dowling P, Donoghue P, Buffini M and Ohlendiec K: Reduced expression of regucalcin in young and aged mdx diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle. Biochim Biophys Acta 1764: 773-785, 2006.
41. Gulston MK, Rubtsov DV, Atherton HJ, Clarke K, Davies KE, Lilley KS and Griffin JL: A combined metabolomic and proteomic investigation of the effects of a failure to express dystrophin in the mouse heart. J Proteome Res 7: 2069-2077, 2008.
42. Kragstrup TW, Kjaer M and Mackey AL: Structural, biochemical, cellular, and functional changes in skeletal muscle extracellular matrix with aging. Scand J Med Sci Sports 21: 749-757, 2011.
43. Goldspink G, Fernandes K, Williams PE and Wells DJ: Age-related changes in collagen gene expression in the muscles of mdx dystrophic and normal mice. Neuromuscul Disord 4: 183-191, 1994.
44. Graham KM, Singh R, Millman G, Malnassy G, Gatti F, Bruemmer K, Stefanski C, Curtis H, Sesti J and Carlson CG: Excessive collagen accumulation in dystrophic (mdx) respiratory musculature is independent of enhanced activation of the NF-kappaB pathway. J Neurol Sci 294: 43-50, 2010.
45. Trensz F, Haroun S, Cloutier A, Richter MV and Grenier G: A muscle resident cell population promotes fibrosis in hindlimb skeletal muscles of mdx mice through the Wnt canonical pathway. Am J Physiol Cell Physiol 299: C939-C947, 2010.
46. Okamoto O and Fujiwara S: Dermatopontin, a novel player in the biology of the extracellular matrix. Connect Tissue Res 47: 177-189, 2006.
47. Forbes EG, Cronshaw AD, MacBeath JR and Hulmes DJ: Tyrosine-rich acidic matrix protein (TRAMP) is a tyrosine-sulphated and widely distributed protein of the extracellular matrix. FEBS Lett 351: 433-436, 1994.
48. Kato A, Okamoto O, Ishikawa K, Sumiyoshi H, Matsuo N, Yoshioka H, Nomizu M, Shimada T and Fujiwara S: Dermatopontin interacts with fibronectin, promotes fibronectin fibril formation, and enhances cell adhesion. J Biol Chem 286: 14861-14869, 2011.
49. Vidal B, Serrano AL, Tjwa M, Suelves M, Ardite E, De Mori R, Baeza-Raja B, Martinez de Lagran M, Lafuste P, Ruiz-Bonilla V, et al: Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway. Genes Dev 22: 1747-1752, 2008.
50. Ishizaki M, Suga T, Kimura E, Shiota T, Kawano R, Uchida Y, Uchino K, Yamashita S, Maeda Y and Uchino M: Mdx respiratory impairment following fibrosis of the diaphragm. Neuromuscul Disord 18: 342-348, 2008.